SuperworthCEL SCI market cap CVM
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $28.8M
- Highest close in our data
- $1.2B
- Jun 2021
CEL SCI is worth $28.8M at the close on Oct 23, 2026, at $1.64 a share.
That is down 54% over the last year and down 95% over five years.
Its highest close in our data was $1.2B in Jun 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $28.8M | $8.8M | $49M | −27% |
| 2025 | $39.6M | $7.6M | $72.2M | −11% |
| 2024 | $44.3M | $36.9M | $172.7M | −73% |
| 2023 | $163.1M | $60.7M | $164.9M | +32% |
| 2022 | $123.2M | $108.2M | $343M | −67% |
| 2021 | $368.4M | $368.4M | $1.2B | −32% |
| 2020 | $540.4M | $330.3M | $742.5M | +48% |
| 2019 | $364.3M | $89.6M | $388M | +270% |
| 2018 | $98.5M | $13.9M | $114.4M | +365% |
| 2017 | $21.2M | $17.8M | $30.3M | +34% |
| 2016 | $15.9M | $15.9M | $100.7M | −73% |
| 2015 | $57.7M | $55.1M | $123M | −16% |
| 2014 | $69.1M | $38.8M | $122.8M | +209% |
| 2013 | $22.3M | $22.3M | $103.8M | −75% |
| 2012 | $88.5M | $80M | $158.7M | +11% |
| 2011 | $80M | $71.5M | $102.1M | n/a |
Against its peers
Companies in Healthcare nearest CEL SCI's size, closest first, today.
| Company | Market cap |
|---|---|
| CVMCEL SCI | $28.8M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on CEL SCI
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.